Walleye Trading
CLOV icon

Walleye Trading’s Clover Health Investments CLOV Stock Holding History

Walleye Trading’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
38,800
+1,800
+5% +$6.11K ﹤0.01% 3128
2026
Q1 		$65.1K Sell
37,000
-177,200
-83% -$384K ﹤0.01% 3609
2025
Q4 		$503K Buy
214,200
+199,100
+1,319% +$544K ﹤0.01% 2818
2025
Q3 		$46.2K Sell
15,100
-13,200
-47% -$37.7K ﹤0.01% 3983
2025
Q2 		$79K Sell
28,300
-4,000
-12% -$13.2K ﹤0.01% 3682
2025
Q1 		$116K Buy
32,300
+19,000
+143% +$76.3K ﹤0.01% 3329
2024
Q4 		$41.9K Buy
+13,300
New +$47.5K ﹤0.01% 3829
2024
Q2 		– Sell
-10,000
Closed -$7.94K – 4359
2024
Q1 		$7.94K Buy
10,000
+5,300
+113% +$4.82K ﹤0.01% 4351
2023
Q4 		$4.47K Buy
+4,700
New +$4.62K ﹤0.01% 4729
2022
Q2 		– Sell
-7,600
Closed -$27K – 5178
2022
Q1 		$27K Buy
+7,600
New +$22K ﹤0.01% 4691
2021
Q4 		– Sell
-26,900
Closed -$199K – 5406
2021
Q3 		$199K Buy
+26,900
New +$230K ﹤0.01% 3846

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Walleye Trading's CLOV Position: Q2 2026 in Review

Walleye Trading reduced its Clover Health Investments (CLOV) stake by 47% in Q2 2026, selling an estimated $158K and leaving 53,028 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #2966.

Walleye Trading first reported a position in CLOV in Q2 2020 and has held it in 9 quarters since. The position peaked at $2.22M in Q2 2020. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Walleye Trading held 53,028 shares of Clover Health Investments worth $278K as of Q2 2026.
  • Walleye Trading sold 46,455 Clover Health Investments shares in Q2 2026, an estimated $158K.
  • Clover Health Investments made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #2966 holding.
  • Walleye Trading first reported a position in Clover Health Investments in Q2 2020 and has held it in 9 quarters since.
  • Walleye Trading's Clover Health Investments position peaked at $2.22M in Q2 2020.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.